Generic immunizing agent - 1119349007
View generic immunizing agent subset
Concept details
COVID-19 messenger ribonucleic acid unspecified
Pan-Canadian SNOMED CT terminology
- Concept code
- 1119349007
- Concept status
- active
- Version
- 20210331
- Display name
- English: COVID-19 messenger ribonucleic acid unspecified
- French: COVID-19 vaccin à l'acide ribonucléique messager non spécifié
- Abbreviation
- English: COVID-19
- French: COVID-19
- Fully specified name
- Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
Health Canada drug information
Product status
- Cancelled Post Market
- Cancelled Pre Market
- Marketed
Linked concepts
Linked tradename concept(s)
- COVID-19 COMIRNATY (original strain) 30 mcg/0.3 mL mRNA PB
- COVID-19 COMIRNATY (original strain) tris-sucrose 30 mcg/0.3 mL mRNA PB
- COVID-19 COMIRNATY 30 mcg/0.3 mL mRNA PB
- COVID-19 COMIRNATY Omicron XBB.1.5 30 mcg/0.3mL mRNA PB
- COVID-19 COMIRNATY Original & Omicron BA.4/BA.5 30 mcg/0.3 mL mRNA PB
- COVID-19 COMIRNATY Original / Omicron BA.1 30 mcg/0.3 mL mRNA PB
- COVID-19 mRNA CureVac
- COVID-19 SPIKEVAX (original strain) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX (original strain) 0.20 mg/mL mRNA Mod
- COVID-19 SPIKEVAX 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod
- COVID-19 SPIKEVAX XBB.1.5 0.10 mg/mL mRNA Mod
This vaccine protects against the following diseases:
This vaccine contains the following antigens:
National Vaccine Catalogue database details
- Last updated
- 2024-03-24
Concept history
This concept replaces
| Concept code | Display name |
|---|---|
| No data is available | |
Notice
Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.
Disclaimer
The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.
- Version:
- 1.0.12